Clinical Trial Update: Zevalin-beam for Aggressive Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Zevalin-beam in aggressive non-Hodgkin's lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin-beam

Snippet

Sponsor: Sheba Medical Center | Conditions: Non-Hodgkin's Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2020-08-31